Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?Monica Fung, Jennifer M. Babik, Brian S. Schwartz et al.|Clinical Infectious Diseases|2018Cited by 63
Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case SeriesSwetha Kambhampati, Charalambos Andreadis, Lissa Gray et al.|Clinical Lymphoma Myeloma & Leukemia|2019Cited by 24
Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell ImmunotherapySwetha Kambhampati, Sandy W. Wong, Bita Fakhri et al.|Blood|2020Cited by 12
Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotinTiffany Guan, Bita Fakhri, Mimi Lo et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 5
415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole ProphylaxisCatherine DeVoe, Peter Chin‐Hong, Mimi Lo et al.|Open Forum Infectious Diseases|2018Cited by 2